SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

The complex settlement, which hands payouts and royalties to CureVac and partner GSK, comes as BioNTech is inching toward an ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

Notably, Pfizer's Comirnaty COVID vaccine is still approved or authorized for people 6 months of age and older without any ...